CASI Pharmaceuticals Shares Outstanding 2006-2019 | CASI

CASI Pharmaceuticals shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
CASI Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2018 85
2017 62
2016 56
2015 32
2014 29
2013 26
2012 19
2011 12
2010 10
2009 8
2008 8
2007 8
2006 7
2005 4
CASI Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q2 2019 96
Q1 2019 96
Q4 2018 85
Q3 2018 87
Q2 2018 86
Q1 2018 71
Q4 2017 62
Q3 2017 60
Q2 2017 60
Q1 2017 60
Q4 2016 56
Q3 2016 49
Q2 2016 43
Q1 2016 40
Q4 2015 32
Q3 2015 32
Q2 2015 32
Q1 2015 32
Q4 2014 29
Q3 2014 28
Q2 2014 27
Q1 2014 27
Q4 2013 26
Q3 2013 27
Q2 2013 27
Q1 2013 23
Q4 2012 19
Q3 2012 23
Q2 2012 19
Q1 2012 12
Q4 2011 12
Q3 2011 12
Q2 2011 12
Q1 2011 11
Q4 2010 10
Q3 2010 10
Q2 2010 9
Q1 2010 9
Q4 2009 8
Q3 2009 8
Q2 2009 7
Q1 2009 8
Q4 2008 8
Q3 2008 8
Q2 2008 8
Q1 2008 8
Q4 2007 8
Q3 2007 8
Q2 2007 8
Q1 2007 8
Q4 2006 7
Q3 2006 7
Q2 2006 7
Q1 2006 6
Q4 2005 4
Q3 2005 5
Q2 2005 5
Q1 2005 4
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.306B $0.000B
CASI Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the acquisition, development and commercialization of proprietary therapeutics for the treatment of cancer and other diseases for the global markets, with a focus on China. The Company's products present antiangiogenic solutions to cancer, cardiovascular disease, and macular degeneration. CASI Pharmaceuticals Inc., formerly known as EntreMed, Inc., is headquartered in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.196B 37.07
Astellas Pharma (ALPMY) Japan $26.780B 13.13
Takeda Pharmaceutical (TAK) Japan $26.201B 8.18
Grifols, S.A (GRFS) Spain $15.161B 19.34
UCB SA (UCBJF) Belgium $15.008B 0.00
Eisai (ESALY) Japan $14.716B 25.30
Merck (MKGAF) Germany $13.654B 18.63
Ionis Pharmaceuticals (IONS) United States $9.973B 21.51
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $8.886B 0.00
IPSEN SA ADR (IPSEY) France $8.634B 0.00
Sage Therapeutics (SAGE) United States $8.507B 0.00
Catalent (CTLT) United States $8.127B 32.61
Jazz Pharmaceuticals (JAZZ) Ireland $7.726B 10.17
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.954B 17.81
FibroGen (FGEN) United States $3.877B 96.98
United Therapeutics (UTHR) United States $3.565B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.197B 73.30
Taro Pharmaceutical Industries (TARO) Israel $3.140B 11.25
Evotec AG (EVTCY) Germany $3.032B 41.51
Nektar Therapeutics (NKTR) United States $2.999B 0.00
Tilray (TLRY) Canada $2.849B 0.00
PTC Therapeutics (PTCT) United States $2.695B 0.00
Xencor (XNCR) United States $2.309B 50.35
Zogenix (ZGNX) United States $2.148B 0.00
Portola Pharmaceuticals (PTLA) United States $1.974B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.580B 57.50
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.491B 14.95
Corcept Therapeutics (CORT) United States $1.468B 20.17
Heron Therapeutics (HRTX) United States $1.437B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.424B 23.49
Ironwood Pharmaceuticals (IRWD) United States $1.380B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.218B 0.00
ArQule (ARQL) United States $1.110B 0.00
Radius Health (RDUS) United States $1.059B 0.00
Aerie Pharmaceuticals (AERI) United States $1.034B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.919B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.828B 3.69
Endo (ENDP) Ireland $0.684B 1.20
TherapeuticsMD (TXMD) United States $0.661B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.636B 0.00
Indivior (INVVY) United States $0.575B 2.08
Karyopharm Therapeutics (KPTI) United States $0.572B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.540B 0.00
Akebia Therapeutics (AKBA) United States $0.534B 0.00
Dermira (DERM) United States $0.482B 0.00
Concordia (CXRXF) Canada $0.479B 0.00
Aptorum Group (APM) China $0.464B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.457B 0.00
Translate Bio (TBIO) United States $0.443B 0.00
Dova Pharmaceuticals (DOVA) United States $0.429B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.427B 19.43
ChemoCentryx (CCXI) United States $0.410B 0.00
ImmunoGen (IMGN) United States $0.409B 0.00
Flexion Therapeutics (FLXN) United States $0.407B 0.00
Siga Technologies (SIGA) United States $0.405B 0.95
Organogenesis Holdings (ORGO) United States $0.400B 0.00
Collegium Pharmaceutical (COLL) United States $0.397B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.365B 0.00
CV Sciences (CVSI) United States $0.340B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.323B 0.00
Xeris Pharmaceuticals (XERS) United States $0.314B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.296B 0.00
KalVista Pharmaceuticals (KALV) United States $0.290B 0.00
Rafael Holdings (RFL) United States $0.282B 0.00
Harpoon Therapeutics (HARP) United States $0.280B 0.00
CannTrust Holdings (CTST) Canada $0.277B 0.00
Lannett Co Inc (LCI) United States $0.277B 2.69
La Jolla Pharmaceutical (LJPC) United States $0.270B 0.00
DURECT (DRRX) United States $0.263B 0.00
OptiNose (OPTN) United States $0.263B 0.00
Recro Pharma (REPH) United States $0.259B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.251B 0.00
Concert Pharmaceuticals (CNCE) United States $0.246B 0.00
Ocular Therapeutix (OCUL) United States $0.218B 0.00
Calithera Biosciences (CALA) United States $0.213B 0.00
Ardelyx (ARDX) United States $0.197B 0.00
Molecular Templates (MTEM) United States $0.185B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.183B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.177B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 29.26
Taiwan Liposome (TLC) Taiwan $0.171B 0.00
Redhill Biopharma (RDHL) Israel $0.155B 0.00
GlycoMimetics (GLYC) United States $0.146B 0.00
IMV INC (IMV) Canada $0.145B 0.00
Generex Biotechnology (GNBT) United States $0.137B 0.00
Majesco Entertainment (PTE) United States $0.133B 0.00
Jounce Therapeutics (JNCE) United States $0.123B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.121B 0.00
MEI Pharma (MEIP) United States $0.120B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.114B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.111B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
AgeX Therapeutics (AGE) United States $0.101B 0.00
Cardiome Pharma (CORV) Canada $0.097B 0.00
Mast Therapeutics (SVRA) United States $0.096B 0.00
Aquestive Therapeutics (AQST) United States $0.095B 0.00
Neos Therapeutics (NEOS) United States $0.094B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Nivalis Therapeutics (ALPN) United States $0.089B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.083B 31.94
Genocea Biosciences (GNCA) United States $0.083B 0.00
MediWound (MDWD) Israel $0.080B 0.00
RENEURON GP (RNUGF) United Kingdom $0.080B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.078B 0.00
Natural Alternatives (NAII) United States $0.075B 7.52
Otonomy (OTIC) United States $0.072B 0.00
China SXT Pharmaceuticals (SXTC) China $0.071B 0.00
Champions Oncology (CSBR) United States $0.068B 589.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Novan (NOVN) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.060B 0.00
Pharmaxis (PXSLY) Australia $0.060B 0.00
Capnia (SLNO) United States $0.060B 0.00
Lipocine (LPCN) United States $0.060B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
ElectroCore (ECOR) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.044B 0.00
India Globalization Capital (IGC) United States $0.040B 0.00
CTI BioPharma (CTIC) United States $0.040B 0.00
Aclaris Therapeutics (ACRS) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Bio-Path Holdings (BPTH) United States $0.036B 0.00
Melinta Therapeutics (MLNT) United States $0.034B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Biomerica (BMRA) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Opexa Therapeutics (ACER) United States $0.023B 0.00
IsoRay (ISR) United States $0.023B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 1.44
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.015B 0.00
Achieve Life Sciences (ACHV) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.014B 0.00
Onconova Therapeutics (ONTX) United States $0.014B 0.00
Shineco (TYHT) China $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.007B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00